Vascular Response of the Segments Adjacent to the Proximal and Distal Edges of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold: 6-Month and 1-Year Follow-Up Assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vascular Response of the Segments Adjacent to the Proximal and Distal Edges of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold: 6-Month and 1-Year Follow-Up Assessment

Published:2012-06 Issue:6 Volume:5 Page:656-665
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Gogas Bill D.,Serruys Patrick W.,Diletti Roberto,Farooq Vasim,Brugaletta Salvatore,Radu Maria D.,Heo Jung Ho,Onuma Yoshinobu,van Geuns Robert-Jan M.,Regar Evelyn,De Bruyne Bernard,Chevalier Bernard,Thuesen Leif,Smits Pieter C.,Dudek Dariusz,Koolen Jacques,Windecker Stefan,Whitbourn Robert,Miquel-Hebert Karine,Dorange Cecile,Rapoza Richard,Garcia-Garcia Hector M.,McClean Dougal,Ormiston John A.

Funder

Abbott

Adamed

AstraZeneca

Biotronik

Balton

Bayer

BBraun

BioMatrix

Boston Scientific

Boehringer-Ingelheim

Bristol-Myers Squibb

Cordis

Cook

Eli Lilly & Co.

EuroCor

GlaxoSmithKline

Invatec, Medtronic

The Medicines Company

MSD

Nycomed

Orbus-Neich

Pfizer

Possis

Promed

Sanofi-Aventis

Siemens

Solvay

Terumo

Tyco

Biosensors

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial);Costa;Am J Cardiol,2008

2. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions;Grube;Circulation,2003

3. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial;Serruys;Circulation,2004

4. Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) study;García-García;Rev Esp Cardiol,2008

5. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents;Chieffo;Am J Cardiol,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary bioresorbable stents: Non-invasive quantitative evaluation of intra- and juxta-stent plaque composition—A computed tomography longitudinal study;PLOS ONE;2022-10-13

2. Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug‐eluting stents;Catheterization and Cardiovascular Interventions;2021-06-24

3. Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial;IJC Heart & Vasculature;2020-12

4. Latest generation stents: is it time to revive the bioresorbable scaffold?;Minerva Cardioangiologica;2020-11

5. Planned use of GP IIb/IIIa inhibitors is safe and effective during implantation of the Absorb Bioresorbable Vascular Scaffold;Cardiovascular Revascularization Medicine;2018-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3